2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。出版社推荐: | 热 美国化学会ACS期刊一览 | 新 IF 2.9,JCR Q2 神经系统基础研究期刊征稿中 | 新 开放获取选刊时如何避雷?点击查看干货指南! |
基本信息 | 登录收藏 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Cancer Biomarkers CANCER BIOMARK (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.1
52人评分
我要评分
声誉 4.1 影响力 5.2 速度 8.5 | |||||||||||||||||||||||||
期刊ISSN | 1574-0153 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
E-ISSN | 1875-8592 | |||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 2.2 点击查看影响因子趋势图 | |||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:1.368 | |||||||||||||||||||||||||
2023-2024自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||||||
五年影响因子 | 2.3 | |||||||||||||||||||||||||
JCI期刊引文指标 | 0.64 | |||||||||||||||||||||||||
h-index | 33 | |||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||
期刊官方网站 | http://www.iospress.nl/journal/cancer-biomarkers/ | |||||||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/CBM | |||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Biomarkers的语言要求,还能让Cancer Biomarkers编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Biomarkers编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||||||||||
通讯方式 | IOS PRESS, NIEUWE HEMWEG 6B, AMSTERDAM, NETHERLANDS, 1013 BG | |||||||||||||||||||||||||
出版商 | IOS Press | |||||||||||||||||||||||||
涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||||||
出版国家或地区 | NETHERLANDS | |||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||||||
出版年份 | 2005 | |||||||||||||||||||||||||
年文章数 | 91点击查看年文章数趋势图 | |||||||||||||||||||||||||
Gold OA文章占比 | 6.10% | |||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 98.90% | |||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:3区
| |||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:预警等级:中 | |||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-0153%5BISSN%5D | |||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均3.0个月 | |||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 约50% | |||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Biomarkers顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | ScRNA-seq revealed targeting regulator of G protein signaling 1 to mediate regulatory T cells in Hepatocellular carcinoma Author: Zou, Lianhong; Liu, Kaihua; Shi, Yongzhong; Li, Guowei; Li, Haiyang; Zhao, Chaoxian Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 299-311. DOI: 10.3233/CBM-220226 PubMed DOI |
2. | Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma Author: Zhang, Chengpeng; Huang, Yong; Fang, Chen; Liang, Yingkuan; Jiang, Dong; Li, Jiaxi; Ma, Haitao; Jiang, Wei; Feng, Yu Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 313-326. DOI: 10.3233/CBM-220227 PubMed DOI |
3. | Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment Author: Yin, Zi; Ma, Tingting; Chen, Sheng; Yu, Min Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 3, pp. 231-250. DOI: 10.3233/CBM-210300 PubMed DOI |
4. | LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression Author: Yao, Weitao; Hou, Jingyu; Liu, Guoqing; Wu, Fangxing; Yan, Qiang; Guo, Liangyu; Wang, Chuchu Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 1, pp. 1-16. DOI: 10.3233/CBM-210291 PubMed DOI |
5. | MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53 Author: Yang, Yun; Luo, Yanyan; Huang, Shuting; Tao, Yonghui; Li, Chuanyin; Wang, Chengcheng Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 267-278. DOI: 10.3233/CBM-210559 PubMed DOI |
6. | Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients Author: Wu, Mengni; Lu, Linlin; Dai, Tiantian; Li, Aoshuang; Yu, Yue; Li, Yadi; Xu, Zhihua; Chen, Yan Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 1, pp. 83-96. DOI: 10.3233/CBM-210545 PubMed DOI |
7. | Elevated expression of TNFRSF4 impacts immune cell infiltration and gene mutation in hepatocellular carcinoma Author: Wang, Di; Hu, Huan; Ding, Huan; Zhao, Han; Tian, Feifei; Chi, Qingjia Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 2, pp. 147-159. DOI: 10.3233/CBM-210538 PubMed DOI |
8. | The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study Author: Wang, Cheng; Lin, Tingting; Chen, Xin; Cui, Wenjing; Guo, Chuangen; Wang, Zhongqiu; Chen, Xiao Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 4, pp. 279-286. DOI: 10.3233/CBM-220080 PubMed DOI |
9. | Overexpression of lncRNA TUG1 enhances the efficacy of DC-CIK immunotherapy in neuroblastoma in vitro and in vivo Author: Tan, Wei-Qiang; Yuan, Li; Cao, Xu; Wu, Xiao-Yuan; Xing, Yi-Qun; Ye, Ming Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 1, pp. 53-61. DOI: 10.3233/CBM-210436 PubMed DOI |
10. | Role of gene signature regulation in tumor immune microenvironment on the mechanism of uveal melanoma metastasis Author: Shi, Kai; Tang, Jiatian; Yuan, Lingyan; Zhou, Shengwen; Ran, Wei; Wang, Zhiming Journal: CANCER BIOMARKERS. 2023; Vol. 36, Issue 2, pp. 161-175. DOI: 10.3233/CBM-210427 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室